Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 29;14(20):14051-14067.
doi: 10.1039/d4ra01937g. eCollection 2024 Apr 25.

Novel isatin-triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies

Alia Mushtaq  1 , Rabbia Asif  1 , Waqar Ahmed Humayun  2 , Muhammad Moazzam Naseer  1
Affiliations

Novel isatin-triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies

Alia Mushtaq et al. RSC Adv. .

Abstract

Thiosemicarbazones of isatin have been found to exhibit versatile bioactivities. In this study, two distinct types of isatin-triazole hybrids 3a and 3b were accessed via copper-catalyzed azide-alkyne cycloaddition reaction (CuAAC), together with their mono and bis-thiosemicarbazone derivatives 4a-h and 5a-h. In addition to the characterization by physical, spectral and analytical data, a DFT study was carried out to obtain the optimized geometries of all thiosemicarbazones. The global reactivity values showed that among the synthesized derivatives, 4c, 4g and 5c having nitro substituents are the most soft compounds, with compound 5c having the highest electronegativity and electrophilicity index values among the synthesized series, thus possessing strong binding ability with biomolecules. Molecular docking studies were performed to explore the inhibitory ability of the selected compounds against the active sites of the anticancer protein of phosphoinositide 3-kinase (PI3K). Among the synthesized derivatives, 4-nitro substituted bisthiosemicarbazone 5c showed the highest binding energy of -10.3 kcal mol-1. These findings demonstrated that compound 5c could be used as a favored anticancer scaffold via the mechanism of inhibition against the PI3K signaling pathways.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Some biologically active isatin derivatives as anticancer agents.
Scheme 1
Scheme 1. Synthesis of isatin–triazole hybrids 3a and 3b; reagents and conditions: (i) dibromoethane (2.1 eq.), DMF, K2CO3 (ii) NaN3 (1.2 eq.), DMF(iii) propargyl bromide, DMF, K2CO3 (iv) CuSO4·5H2O, sodium ascorbate, EtOH : H2O (9 : 1), rt.
Scheme 2
Scheme 2. Synthesis of mono and bis-thiosemicarbazones (4a–h and 5a–h) of isatin–triazole hybrids (3a and 3b); reagents and conditions: (v) N4-substituted thiosemicarbazides (1.1 eq.), EtOH, rt; (vi) N4-substituted thiosemicarbazides (2.1 eq.), EtOH, CH3COOH (cat.), reflux.
Fig. 2
Fig. 2. HOMO and LUMO of 3b, 4c, 4g and 5c.
Fig. 3
Fig. 3. Diagrammatic representation of molecular interactions of the ligand molecules (3b, 4c, 4g and 5c) with various amino acid residues in the binding pocket of the protein PI3K.
See this image and copyright information in PMC

References

    1. Mushtaq A. Wu P. Naseer M. M. Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets. Pharmacol. Ther. 2024;254:108579. - PubMed
    1. Eftekhari-Sis B. Zirak M. Akbari A. Arylglyoxals in synthesis of heterocyclic compounds. Chem. Rev. 2013;113(5):2958–3043. - PubMed
    1. Al-Warhi T. Elimam D. M. Elsayed Z. M. Abdel-Aziz M. M. Maklad R. M. Al-Karmalawy A. A. Afarinkia K. Abourehab M. A. Abdel-Aziz H. A. Eldehna W. M. Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens. RSC Adv. 2022;12(48):31466–31477. - PMC - PubMed
    1. Wang Y. Liang Z. Zheng Y. Leung A. S.-L. Yan S.-C. So P.-K. Leung Y.-C. Wong W.-L. Wong K.-Y. Rational structural modification of the isatin scaffold to develop new and potent antimicrobial agents targeting bacterial peptidoglycan glycosyltransferase. RSC Adv. 2021;11(29):18122–18130. - PMC - PubMed
    1. Katiyar A. Hegde M. Kumar S. Gopalakrishnan V. Bhatelia K. D. Ananthaswamy K. Ramareddy S. A. De Clercq E. Choudhary B. Schols D. Synthesis and evaluation of the biological activity of N′-[2-oxo-1, 2 dihydro-3 H-indol-3-ylidene] benzohydrazides as potential anticancer agents. RSC Adv. 2015;5(56):45492–45501.